A report, titled, “Allergy-Relieving Eye Drops Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024,” by Transparency Market Research foretells mammoth revenue gains in this market due to rising cases of eye infections and allergies occurring all over the globe.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14933
Rising pollution levels across the globe, particularly in the last one decade, has resulted in increasing cases of eye irritation along with with conjunctivitis, stye, and contact dermatitis. And this has been the main driver of the global allergy-relieving eye drops market. Other factors such as proliferation of dust, pollen, and pet dander is also responsible for pushing the market to achieve profitable revenues. Besides, emergence of better products is another factor fuelling the market.
The global allergy-relieving eye drops market is segmented on the basis of class and region. Depending on ‘class,’ the market consists of five primary segments, viz. mast cell stabilizers, anti-inflammatory, antihistamines, decongestant, mast cell stabilizers, and multiple action. Due to over-the-counter availability of many mast cell stabilizers, this segment is experiencing maximum demand from consumers. Region-wise, the global allergy-relieving eye drops market is segmented into Asia-Pacific, Europe, North America, and the Rest of the World. Ease in availability of eye drops and high occurrence of these diseases in North America has made it gain maximum revenue based on product sales.
The vendor landscape of the global allergy-relieving eye drops market is highly fragmented owing to innumerable companies operating in it. This also makes the market competitive, wherein most players are seen focusing on product development, aggressive marketing, and regional expansions to outshine their rivals. Chief companies in the global allergy-relieving eye drops market are Meda Pharmaceuticals Inc., Novartis AG, Cigna, Allergan, Inc., Bausch & Lomb Inc., and Similasan Corporation.